Top Authors

• Most frequent coverage on SNTS

• 
  Mike Havrilla (1966 followers)

  • Extreme FDA Trades: 30 Stocks Under 5 Bucks (Sun, Aug 2)
  • FDA Extreme Trades: 16 Stocks Under 5 Bucks (Sun, Jun 28)
  • FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS (Tue, Jun 23)

  More by Mike Havrilla on SNTS »
• 
  R. Saito (29 followers)

  • Santarus' Zegrid Facing Back-to-Back FDA Approval Dates (Fri, Nov 20)
  • Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza (Mon, Nov 16)

  More by R. Saito on SNTS »
• 
  SA Editor Miriam Metzinger (562 followers)

  • Jim Cramer's Mad Money In-Depth Stock Picks, Oct. 19 (Fri, Oct 20)

  More by SA Editor Miriam Metzinger on SNTS »

• Most followed authors on SNTS

• 
  Mike Havrilla (1966 followers)

  • Extreme FDA Trades: 30 Stocks Under 5 Bucks (Sun, Aug 2)
  • FDA Extreme Trades: 16 Stocks Under 5 Bucks (Sun, Jun 28)
  • FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS (Tue, Jun 23)

  More by Mike Havrilla on SNTS »
• 
  Zacks.com (1115 followers)

  • Santarus: Business Fundamentals Improving (Sun, Jun 21)

  More by Zacks.com on SNTS »
• 
  J Clinton Hill (981 followers)

  • Three Top and Bottom Market Sectors for This Week (Sun, Jun 21)

  More by J Clinton Hill on SNTS »

• Newest authors on SNTS

• 
  R. Saito (29 followers)

  • Santarus' Zegrid Facing Back-to-Back FDA Approval Dates (Fri, Nov 20)
  • Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza (Mon, Nov 16)

  More by R. Saito on SNTS »
• 
  ThreeBrothersHealth.com (14 followers)

  • Santarus: Business Fundamentals Are Unchanged (Wed, Jun 24)

  More by ThreeBrothersHealth.com on SNTS »
• 
  Michael Becker (176 followers)

  • Biotech’s 2009 Stealth Small Cap Rally (Mon, Jan 4)

  More by Michael Becker on SNTS »

• Most commented on SNTS

• 
  Mike Havrilla (1966 followers)

  • Extreme FDA Trades: 30 Stocks Under 5 Bucks (Sun, Aug 2)
  • FDA Extreme Trades: 16 Stocks Under 5 Bucks (Sun, Jun 28)
  • FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS (Tue, Jun 23)

  More by Mike Havrilla on SNTS »
• 
  Zacks.com (1115 followers)

  • Santarus: Business Fundamentals Improving (Sun, Jun 21)

  More by Zacks.com on SNTS »
• 
  R. Saito (29 followers)

  • Santarus' Zegrid Facing Back-to-Back FDA Approval Dates (Fri, Nov 20)
  • Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza (Mon, Nov 16)

  More by R. Saito on SNTS »